Amneal Pharmaceuticals, Inc. (AMRX)
NYSE$8.62
Market Cap
$3.98B
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
451 of 924
Rank in Industry
22 of 56
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
AMRX Insider Trading Activity
AMRX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $49,750,591 | 20 | 100 |
Related Transactions
| Kiely John | director | 0 | $0 | 1 | $142,946 | $-142,946 |
| Autor Deborah M. | director | 0 | $0 | 4 | $590,180 | $-590,180 |
| Alva Emily Peterson | director | 0 | $0 | 1 | $712,000 | $-712,000 |
| Shah Nikita | Executive Vice President | 0 | $0 | 1 | $775,000 | $-775,000 |
| Konidaris Tasos | Executive Vice President & CFO | 0 | $0 | 1 | $891,000 | $-891,000 |
| Daly Jason B. | SVP, Chief Legal Officer | 0 | $0 | 4 | $1.28M | $-1.28M |
| BOYER ANDREW S | Executive Vice President | 0 | $0 | 3 | $1.6M | $-1.6M |
| Patel Gautam | director | 0 | $0 | 4 | $2M | $-2M |
| Patel Tushar Bhikhubhai | 10 percent owner | 0 | $0 | 1 | $41.75M | $-41.75M |
About Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in …
Insider Activity of Amneal Pharmaceuticals, Inc.
Over the last 12 months, insiders at Amneal Pharmaceuticals, Inc. have bought $0 and sold $49.75M worth of Amneal Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Amneal Pharmaceuticals, Inc. have bought $802,275 and sold $11.84M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 50,000 shares for transaction amount of $210,500 was made by Patel Gautam (director) on 2021‑12‑17.
List of Insider Buy and Sell Transactions, Amneal Pharmaceuticals, Inc.
| 2025-03-14 | Sale | Patel Tushar Bhikhubhai | 10 percent owner | 5M 1.0326% | $8.35 | $41.75M | -1.49% | |
| 2025-03-06 | Sale | Daly Jason B. | EVP, Chief Legal Officer | 46,936 0.0101% | $8.73 | $409,751 | 0.00% | |
| 2025-03-05 | Sale | Konidaris Tasos | Executive Vice President & CFO | 100,000 0.0214% | $8.91 | $891,000 | -2.12% | |
| 2025-03-05 | Sale | BOYER ANDREW S | Executive Vice President | 125,000 0.0267% | $8.89 | $1.11M | -2.12% | |
| 2025-03-05 | Sale | Alva Emily Peterson | director | 80,000 0.0171% | $8.90 | $712,000 | -2.12% | |
| 2025-03-05 | Sale | Daly Jason B. | EVP, Chief Legal Officer | 43,064 0.0092% | $8.88 | $382,408 | -2.12% | |
| 2025-03-03 | Sale | Patel Gautam | director | 80,000 0.0176% | $8.90 | $712,000 | +0.34% | |
| 2025-02-03 | Sale | Patel Gautam | director | 80,000 0.0171% | $8.14 | $651,200 | +3.03% | |
| 2025-01-08 | Sale | Patel Gautam | director | 62,590 0.0135% | $8.01 | $501,346 | +4.56% | |
| 2025-01-02 | Sale | Patel Gautam | director | 17,410 0.0039% | $8.01 | $139,454 | +7.02% | |
| 2024-11-22 | Sale | Kiely John | director | 17,058 0.0037% | $8.38 | $142,946 | -2.26% | |
| 2024-11-22 | Sale | Autor Deborah M. | director | 33,229 0.0072% | $8.34 | $277,130 | -2.26% | |
| 2024-11-21 | Sale | Autor Deborah M. | director | 6,771 0.0015% | $8.41 | $56,944 | -1.20% | |
| 2024-11-21 | Sale | Daly Jason B. | SVP, Chief Legal Officer | 13,665 0.003% | $8.40 | $114,786 | -1.20% | |
| 2024-11-15 | Sale | Daly Jason B. | SVP, Chief Legal Officer | 43,657 0.0136% | $8.61 | $375,887 | -2.48% | |
| 2024-08-15 | Sale | BOYER ANDREW S | Executive Vice President | 40,225 0.0136% | $7.85 | $315,766 | +6.83% | |
| 2024-08-14 | Sale | BOYER ANDREW S | Executive Vice President | 22,486 0.0076% | $7.81 | $175,616 | +8.19% | |
| 2024-08-14 | Sale | Shah Nikita | Executive Vice President | 100,000 0.0335% | $7.75 | $775,000 | +8.19% | |
| 2024-05-17 | Sale | Autor Deborah M. | director | 23,447 0.0076% | $6.73 | $157,728 | +19.94% | |
| 2024-05-16 | Sale | Autor Deborah M. | director | 14,553 0.0047% | $6.76 | $98,378 | +20.96% |
Total: 60
*Gray background shows transactions not older than one year
Insider Historical Profitability
3.46%
| Patel Gautam | director | 1808886 0.3915% | $15.59M | 3 | 4 | +0.6% |
| BOYER ANDREW S | Executive Vice President | 290106 0.0628% | $2.5M | 2 | 4 | <0.0001% |
| Kiely John | director | 267175 0.0578% | $2.3M | 1 | 1 | +5.19% |
| Patel Chintu | Co-CEO | 512566 0.1109% | $4.42M | 6 | 0 | +5.05% |
| Patel Chirag K. | President & Co-CEO | 512566 0.1109% | $4.42M | 6 | 0 | +5.05% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$910,099,463 | 123 | 11.52% | $2.58B | |
$14,599,168 | 59 | 12.79% | $1.4B | |
$23,522,750 | 59 | -6.74% | $5.35B | |
$86,177,559 | 48 | 44.65% | $13.98B | |
$97,642,477 | 41 | -10.58% | $844.43M |
AMRX Institutional Investors: Active Positions
| Increased Positions | 125 | +75.3% | 10M | +6.68% |
| Decreased Positions | 66 | -39.76% | 26M | -18.29% |
| New Positions | 41 | New | 2M | New |
| Sold Out Positions | 25 | Sold Out | 3M | Sold Out |
| Total Postitions | 225 | +35.54% | 126M | -11.61% |
AMRX Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $129,867.00 | 4.79% | 14.84M | +218,025 | +1.49% | 2024-12-31 |
| Blackrock, Inc. | $110,145.00 | 4.06% | 12.59M | +177,458 | +1.43% | 2024-12-31 |
| Tpg Gp A, Llc | $107,877.00 | 3.98% | 12.33M | 0 | 0% | 2024-12-31 |
| Rubric Capital Management Lp | $93,816.00 | 3.46% | 10.72M | 0 | 0% | 2024-12-31 |
| Citadel Advisors Llc | $78,583.00 | 2.9% | 8.98M | +88,675 | +1% | 2024-12-31 |
| Dimensional Fund Advisors Lp | $43,677.00 | 1.61% | 4.99M | +278,653 | +5.91% | 2024-12-31 |
| Geode Capital Management, Llc | $33,366.00 | 1.23% | 3.81M | +26,536 | +0.7% | 2024-12-31 |
| Neuberger Berman Group Llc | $32,924.00 | 1.21% | 3.76M | -24,918 | -0.66% | 2024-12-31 |
| State Street Corp | $32,359.00 | 1.19% | 3.7M | +183,425 | +5.22% | 2024-12-31 |
| Nantahala Capital Management, Llc | $32,073.00 | 1.18% | 3.67M | +995,586 | +37.29% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.